Treatment failure due to methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to vancomycin

被引:60
作者
Ward, PB
Johnson, PDR
Grabsch, EA
Mayall, BC
Grayson, ML
机构
[1] Austin & Repatriat Med Ctr, Dept Microbiol, Heidelberg, Vic 3084, Australia
[2] Austin & Repatriat Med Ctr, Dept Infect Dis, Heidelberg, Vic 3084, Australia
关键词
D O I
10.5694/j.1326-5377.2001.tb143681.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We report the first instance in Australia of treatment failure due to a strain of methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to vancomycin - heteroresistant vancomycin-intermediate S. aureus (hVISA). The infection occurred in a 41-year-old man with multiple risk factors. No transmission of the organism to other patients or the environment was detected. This case may herald the beginning of a new phase of staphylococcal resistance in Australia.
引用
收藏
页码:480 / +
页数:5
相关论文
共 24 条
[1]  
Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V48, P1165
[2]   Treatment of methicillin-resistant Staphylococcus aureus infections with quinupristin-dalfopristin in patients intolerant of or failing prior therapy [J].
Drew, RH ;
Perfect, JR ;
Srinath, L ;
Kurkimilis, E ;
Dowzicky, M ;
Talbot, GH .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 46 (05) :775-784
[3]  
FEKETY R, 2000, PRINCIPLES PRACTICE, P382
[4]  
Fridkin SK, 2001, CLIN INFECT DIS, V32, P108, DOI 10.1086/317542
[5]   Emergence of heterogeneous intermediate vancomycin resistance in Staphylococcus aureus isolates in the Dusseldorf area [J].
Geisel, R ;
Schmitz, FJ ;
Thomas, L ;
Berns, G ;
Zetsche, O ;
Ulrich, B ;
Fluit, AC ;
Labischinsky, H ;
Witte, W .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 43 (06) :846-848
[6]   The independent evolution of resistance to ciprofloxacin, rifampicin, and fusidic acid in methicillin-resistant Staphylococcus aureus in Australian teaching hospitals (1990-1995) [J].
Gottlieb, T ;
Mitchell, D .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 42 (01) :67-73
[7]   Activated cell-wall synthesis is associated with vancomycin resistance in methicillin-resistant Staphylococcus aureus clinical strains Mu3 and Mu50 [J].
Hanaki, H ;
Kuwahara-Arai, K ;
Boyle-Vavra, S ;
Daum, RS ;
Labischinski, H ;
Hiramatsu, K .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 42 (02) :199-209
[8]   Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin [J].
Hiramatsu, K ;
Aritaka, N ;
Hanaki, H ;
Kawasaki, S ;
Hosoda, Y ;
Hori, S ;
Fukuchi, Y ;
Kobayashi, I .
LANCET, 1997, 350 (9092) :1670-1673
[9]   Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility [J].
Hiramatsu, K ;
Hanaki, H ;
Ino, T ;
Yabuta, K ;
Oguri, T ;
Tenover, FC .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 40 (01) :135-136
[10]  
Hiramatsu Keiichi, 1998, American Journal of Medicine, V104, p7S, DOI 10.1016/S0002-9343(98)00149-1